Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass

被引：22

作者：

Latham, P ^{[1
]}

Revelis, AF ^{[1
]}

Joshi, GP ^{[1
]}

DiMaio, JM ^{[1
]}

Jessen, ME ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dept Anesthesiol & Pain Management, Dallas, TX 75235 USA

来源：

ANESTHESIOLOGY | 2000年 / 92卷 / 01期

关键词：

activated partial thromboplastin time; anticoagulation; complications; ecarin clotting time;

D O I：

10.1097/00000542-200001000-00040

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

[No abstract available]

引用

页码：263 / 266

页数：4

共 13 条

[1]

ADARMES CA, 1998, TECHNOLOGY REPORT AN, P47

[2] ANNOTATION - HEPARIN-INDUCED THROMBOCYTOPENIA [J].

CHONG, BH .

BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) :431-439

[3] Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin [J].

Koster, A ;

Kuppe, H ;

Hetzer, R ;

Sodian, R ;

Crystal, GJ ;

Mertzlufft, F .

ANESTHESIOLOGY, 1998, 89 (03) :777-780

[4]

KOSTER A, 1999, ANESTH ANALG, V88, pS160

[5] CLINICAL-PHARMACOLOGY OF INTRAVENOUSLY ADMINISTERED RECOMBINANT DESULFATOHIRUDIN (CGP-39393) IN HEALTHY-VOLUNTEERS [J].

MARBET, GA ;

VERSTRAETE, M ;

KIENAST, J ;

GRAF, P ;

HOET, B ;

TSAKIRIS, DA ;

SILLINGENGELHARDT, G ;

CLOSE, P .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (03) :364-372

[6] THE DEVELOPMENT OF HIRUDIN AS AN ANTITHROMBOTIC DRUG [J].

MARKWARDT, F .

THROMBOSIS RESEARCH, 1994, 74 (01) :1-23

[7]

NURMOHAMED MT, 1994, THROMB HAEMOSTASIS, V72, P685

[8] Monitoring of recombinant hirudin: Assessment of a plasma-based ecarin clotting time assay [J].

Potzsch, B ;

Hund, S ;

Madlener, K ;

Unkrig, C ;

MullerBerghaus, G .

THROMBOSIS RESEARCH, 1997, 86 (05) :373-383

[9]

Potzsch B, 1997, THROMB HAEMOSTASIS, V77, P920

[10]

REISS FC, 1995, J THORAC CARDIOVASC, V110, P265

← 1 2 →